Why is Parmax Pharma falling/rising?

As of 31-Oct, Parmax Pharma Ltd's stock price is currently at Rs 34.50, reflecting an increase of Rs 2.5 or 7.81%. The stock has been gaining momentum, having outperformed its sector by 8.26% today and achieving a consecutive gain over the last two days, with a total return of 10.08% in that period. Despite this positive movement, the stock has shown a year-to-date decline of 22.03% and a one-year decline of 24.67%, indicating a challenging longer-term performance. Additionally, while the stock has traded in a wide range and exhibited high volatility today, there has been a notable decrease in investor participation, with delivery volume dropping by nearly 50% compared to the five-day average.
Broader Market Context: In the short term, Parmax Pharma's performance has been significantly better than the benchmark Sensex, which has seen a slight decline of 0.32% over the past week, while Parmax has gained 4.51%. This contrast highlights the stock's recent strength relative to the broader market. However, the longer-term picture remains concerning, as the stock has underperformed the Sensex over one year and three years, suggesting that while there may be short-term gains, the overall trend has been negative compared to the market's performance.